文献速递头颈外科咽喉与嗓音

头颈癌治疗后客观与主观唾液减少的长期结局

Objective and subjective hyposalivation after treatment for head and neck cancer: Long-term outcomes.
PubMed 文献 · Laryngoscope · 2018-10-16

本研究为前瞻性队列研究,纳入2010至2016年新诊断的口腔、口咽、鼻咽、喉/下咽癌患者,接受手术+辅助放化疗或原发放化疗。结果显示各治疗组唾液重量在治疗后前3个月内下降最明显,手术+放化疗组持续下降,36个月以上有所改善。唾液重量与饮食、进食生活质量及味觉障碍感知相关。

要点

  • 各治疗组唾液重量在治疗后前3个月下降最明显。
  • 手术+放化疗组唾液重量持续下降,36个月以上有所改善。
  • 唾液重量与饮食、进食生活质量及味觉障碍感知相关。

核心结论

  • 各治疗组及肿瘤部位唾液重量在治疗后均恶化,36个月以上有所改善。
  • 唾液重量与饮食、进食生活质量及味觉障碍感知在各时间点相关。
  • 尽管采用剂量 sparing 的调强放疗,仍需新技术保留唾液分泌以维持生活质量。

研究设计与样本

  • 前瞻性队列研究,在门诊头颈癌中心开展。
  • 患者为新诊断的口腔、口咽、鼻咽、喉/下咽癌,2010至2016年,接受手术+放化疗或原发放化疗。
  • 在治疗前及治疗后1、3、6、12、24、36+个月进行评估。
  • 用Saxon试验评估刺激唾液重量。

主要发现

  • 唾液重量在治疗后前3个月内下降最明显,手术+放化疗组持续下降。
  • 按肿瘤部位分析可见相似趋势。
  • PSS Normalcy of Diet及所有生活质量评分在治疗后下降。
  • EORTC QLQ-H&N35、EAT-10、MDADI Composite、Global及子领域评分、PSS Diet与唾液重量显著相关。

临床怎么用

  • 长期随访中应关注头颈癌治疗后患者的唾液减少及其对饮食和进食生活质量的影响。
  • 唾液重量可作为评估饮食、进食生活质量及味觉障碍的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: This study examined saliva weight over time and its association with diet and patient-rated swallowing, dry mouth, sticky saliva, and dysgeusia quality of life in head and neck cancer (HNCA) patients treated with surgery plus adjuvant chemoradiotherapy (CRT), or primary CRT. STUDY DESIGN: Prospective cohort study in an outpatient HNCA center setting. METHODS: Patients were seen pretreatment, and 1, 3, 6, 12, 24, and 36 + months post-treatment. All had newly diagnosed oral, oropharynx, nasopharynx, larynx/hypopharynx cancer from 2010 to 2016 and were to undergo surgery + CRT or primary CRT. Stimulated saliva weight was assessed with the Saxon test. Diet, eating, dry mouth, and dysgeusia quality of life were assessed and correlated with saliva weight, treatment modality, and tumor site. RESULTS: Saliva weight decreased the most within the first 3 months across treatment groups, except for the surgery + CRT group, which continued to decline. Similar trends were seen by tumor site. Performance Status Scale (PSS) Normalcy of Diet and all quality-of-life scores declined following treatment. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck-35 (EORTC QLQ-H&N35); Eating Assessment Tool (EAT-10); M. D. Anderson Dysphagia Inventory (MDADI) Composite, Global, and subdomain scores; and PSS Diet were significantly correlated with saliva weight. CONCLUSIONS: Saliva weight worsened post-treatment across groups and tumor site, with improvement by 36 + months. Saliva weight correlated with diet, eating quality of life and perception of dysgeusia across time points. Despite dose-sparing intensity-modulated radiation therapy, newer technologies are needed to preserve saliva production and maintain higher quality of life. LEVEL OF EVIDENCE: 2b Laryngoscope, 128:2732-2739, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Likhterov I, Ru M, Ganz C, et al. Objective and subjective hyposalivation after treatment for head and neck cancer: Long-term outcomes. Laryngoscope. 2018. PMID: 30325025. doi:10.1002/lary.27224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。